(Q38349935)

2 September 2017

1 reference

title

Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal (English)

1 reference

2 September 2017

main subject

multiple drug resistance

1 reference

1 reference

Suoyuan Li

1

1 reference

2 September 2017

Wei Sun

2

1 reference

2 September 2017

Hongsheng Wang

3

1 reference

2 September 2017

Dongqing Zuo

4

1 reference

2 September 2017

Yingqi Hua

5

1 reference

2 September 2017

Zhengdong Cai

6

1 reference

2 September 2017

publication date

11 February 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

36

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

1329-1338

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-3181-0

2 September 2017

exact match

0 references

cites work

Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

The epidemiology of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Survival from adolescent cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

High-mobility group nucleosome-binding domain 5 increases drug resistance in osteosarcoma through upregulating autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Inhibition of P-glycoprotein function and expression by kaempferol and quercetin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

The P-glycoprotein transport system and cardiovascular drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Revisiting the ABCs of multidrug resistance in cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Multiple pathways are involved in drug resistance to doxorubicin in an osteosarcoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Increased expression and function of P-glycoprotein in peripheral blood CD56+ cells is associated with the chemoresistance of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Human reduced folate carrier: translation of basic biology to cancer etiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

P-glycoprotein, multidrug resistance and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Protein kinase C regulates ezrin-radixin-moesin phosphorylation in canine osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Targeting DNA topoisomerase II in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

DNA topoisomerases and their poisoning by anticancer and antibacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

The role of glutathione-S-transferase in anti-cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Human osteosarcoma xenografts and their sensitivity to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Effect of variation of ABCB1 and GSTP1 on osteosarcoma survival after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

A systematic review of p53 as a biomarker of survival in patients with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Drug resistance in cancer: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

ERCC polymorphisms and prognosis of patients with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Vector-based Ape1 small interfering RNA enhances the sensitivity of human osteosarcoma cells to endostatin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Resistance of stem-like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Detection and characterization of CD133+ cancer stem cells in human solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

VEGFR, RET, and RAF/MEK/ERK pathway take part in the inhibition of osteosarcoma MG63 cells with sorafenib treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Identification of RIP1 kinase as a specific cellular target of necrostatins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3181-0

Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy

21 January 2018

1 reference

12 December 2020

Sensitization and caffeine potentiation of cisplatin cytotoxicity resulting from introduction of wild-type p53 gene in human osteosarcoma

1 reference

12 December 2020

APEX1 gene amplification and its protein overexpression in osteosarcoma: correlation with recurrence, metastasis, and survival

1 reference

12 December 2020

Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells.

1 reference

12 December 2020

Mechanisms of multidrug resistance in cancer

1 reference

12 December 2020

Livin and Bcl-2 expression in high-grade osteosarcoma

1 reference

12 December 2020

p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3

1 reference

12 December 2020

Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines

1 reference

12 December 2020

[Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance].

1 reference

12 December 2020

Glutathione-associated enzymes in anticancer drug resistance.

1 reference

12 December 2020

Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors.

1 reference

12 December 2020

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group

1 reference

12 December 2020

Association of four ERCC1 and ERCC2 SNPs with survival of bone tumour patients

1 reference

12 December 2020

May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol

1 reference

12 December 2020

Molecular mechanisms of chemoresistance in osteosarcoma (Review).

1 reference

12 December 2020

Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition

1 reference

12 December 2020

TP53Mutations and Outcome in Osteosarcoma: A Prospective, Multicenter Study

1 reference

12 December 2020

1 reference

12 December 2020

Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines.

1 reference

12 December 2020

Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP

1 reference

12 December 2020

Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome

1 reference

12 December 2020

Reversion of P-glycoprotein-mediated multidrug resistance by diallyl trisulfide in a human osteosarcoma cell line

1 reference

12 December 2020

Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines.

1 reference

12 December 2020

Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis

1 reference

12 December 2020

PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma

1 reference

12 December 2020

Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients

1 reference

12 December 2020

10.1007/S13277-015-3181-0

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1016772109

0 references

1 reference